hot selling dop substitution dop substitution Germany

Biosimilar Switching in Germany from March 15, 2024

Classification:Chemical Auxiliary Agent
CAS No.:117-84-0
Other Names:Dioctyl Phthalate
MF:C24H38O4, C24H38O4
EINECS No.:201-557-4
Purity:99%
Type:Plasticizer Colorless Oily Liquid DOP for pvc and rubber
Usage:Coating Auxiliary Agents
MOQ::10 Tons
Package:25kg/drum
Model:Dop Oil For Pvc
Storage:Dry Place

Substitution is permissible between a reference medication and its biosimilars, as well as amongst different biosimilars. Pharmacies can consult Appendix VIIa of the Medicines

Automatic Pharmacy-Level Substitution Of Biosimilars In Germany German physicians’ acceptance of and prescribing experience with biosimilars, on the other hand, is

Online Inquiry

How pharmacist biosimilar substitution would work

Classification:Chemical Auxiliary Agent, Chemical Auxiliary Agent
cas no 117-84-0
Other Names:Dioctyl Phthalate
MF:C24H38O4, C24H38O4
EINECS No.:201-557-4
Purity:99.5% Min
Type:Chemical additives, Chemical dop plasticizer 99%
Usage:Coating Auxiliary Agents, Electronics Chemicals, Leather Auxiliary Agents, Plastic Auxiliary Agents, Rubber Auxiliary Agents
MOQ:200kgs
Package:200kgs/battle
Place of Origin::China
Advantage:Stable

In November 2018, the German Health Ministry tabled the draft GSAV (Gesetzes für mehr Sicherheit in der Arzneimittelversor-gung) bill, which translates to the ‘law for more

In November 2018, the German Health Ministry introduced a draft bill on safety in the supply of pharmaceuticals. The Gesetz für mehr Sicherheit in der Arzneimittelversor-gung

Online Inquiry

Use and substitution of biosimilars

Classification:Chemical Auxiliary Agent
CAS No.:117-84-0
Other Names:Chemical Auxiliary Agent
MF:C24H38O4, C24H38O4
EINECS No.:201-557-4
Purity:99.5% min.
Type:Oil drilling
Usage:Coating Auxiliary Agents, Leather Auxiliary Agents, Plastic Auxiliary Agents, Rubber Auxiliary Agents
MOQ:200kgs
Package:200kgs/battle
Advantage:Stable
Payment:T/T

In our view, the interchangeability of biologicals and substitution at pharmacy level as determined in the the new law for more safety in the supply of pharmaceuticals in Germany (GSAV)

This is the first step before implementing biosimilar substitution in German pharmacies planned in mid-2022, as stated in the 2019 "better safety in drug supply" law (GSAV) (APMHE 63301).

Online Inquiry

Automatic substitution with biosimilars by German

Classification:Chemical Auxiliary Agent, Chemical Auxiliary Agent
cas no 117-84-0
Other Names:DOP, diocty phthalate, 1,2-phthalate
MF:C24H38O4
EINECS No.:201-557-4
Purity:≥99.5%
Type:Plasticizer
Usage:Leather Auxiliary Agents, Plastic Auxiliary Agents, Plasticizer
MOQ:200kgs
Package:200kgs/battle
Shape:Powder
Model:Dop Oil For Pvc
Storage:Dry Place

On 16 Aug 2019, the GSAV came into force. This new law also included legislation with the aim to increase the market share of biosimilars in Germany, through. automatic

While the European Union (EU) is regarded as the most advanced market and the pioneer in the regulation of biosimilar medicines, the biosimilar market in the United States (US) remains

Online Inquiry

Automatic pharmacist substitution of biosimilars in Germany

Classification:Chemical Auxiliary Agent, Chemical Auxiliary Agent
cas no 117-84-0
Other Names:Dioctyl Phthalate
MF:C6H4(COOC8H17)2
EINECS No.:201-557-4
Purity:99.5%, 99.9%min.
Type:Plasticizer
Usage:Petroleum Additives, Plastic Auxiliary Agents, Rubber Auxiliary Agents
MOQ:200kgs
Package:200kgs/battle
Shape:Powder
Place of Origin::China
Advantage:Stable

In November 2018, the German Health Ministry introduced a draft bill on safety in the supply of pharmaceuticals. The Gesetz für mehr Sicherheit in der Arzneimittelversor-gung (GSAV) bill

Biosimilars in Germany 2022. 10/12/2021. Symposium; The "Biosimilars 2022" symposium organised by Forum Institut für Management will focus on the changes in the German

Online Inquiry

Can biosimilars be substituted automatically in Germany?
Pharmacists in Germany may soon be able to carry out automatic substitution of biosimilars in the country. In November 2018, the German Health Ministry introduced a draft bill on safety in the supply of pharmaceuticals.
Will Germany become the first EU5 country to implement automatic biosimilar substitution?
Though there is still significant uncertainty over the specifics of the GSAV, it is likely that, if approved, Germany will become the first EU5 country to implement automatic substitution of biosimilars at the pharmacist level. Automatic Pharmacy-Level Substitution Of Biosimilars In Italy And Spain
Why is Germany introducing a new biosimilar law?
The German Health Ministry has introduced the new law in order to increase adoption of biosimilars, due to the huge potential for cost savings. As few European Union (EU) countries currently allow pharmacist substitution of biosimilars, this would represent a significant change in practice, particularly for Germany.
Is automatic substitution a better strategy for biosimilar uptake than automatic substitution?
This may prove to be a better strategy for biosimilar uptake than automatic substitution, given that physicians’ reticence to switch to biosimilars continues to be one of the main barriers to biosimilar use in the country, despite the increase in familiarity and comfort with biosimilars over the past years. 2
Should Germany implement a pharmacy level substitution policy?
If Germany can successfully implement a pharmacy level substitution policy and reduce costs, there may be significant interest and demand from other EU countries to implement similar policies, notably Norway and Finland to help manage their healthcare budgets.
Will Germany develop a substitute list for the gsav?
Negotiations between Germany’s lower house of parliament, Bundestag, and the Health Ministry on the GSAV are ongoing, but the proposal is that two substitution lists will be developed – a physician and a pharmacist list.